COLGAN ERIN (SVP of Finance) received a stock award from FAETH THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/17/2023ACC: 0001209191-23-010735
Officer· SVP of Finance
Since Feb 2021
+141.35K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
141.35K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30.05K
Price / share
—
Trade value
—
% of position
138.6%
2/15/2023
21.69K→51.73K
Common Stock
Direct
Shares
+21.30K
Price / share
—
Trade value
—
% of position
41.2%
2/15/2023
51.73K→73.03K
Total
Net shares
+51.35K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2023 | A · Award | +30.05K | — | — | 138.6% | 21.69K | 51.73K |
| Common Stock Direct | 2/15/2023 | A · Award | +21.30K | — | — | 41.2% | 51.73K | 73.03K |
| Total | +51.35K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
90K shares
Shares
+90K
Strike price
1.43
Held after
90K
Exercisable
—
2/15/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock90K shares | 2/15/2023 | A · Award | +90K | 1.43 | — | 90K |